Author:
Gupta Akash,Landis Ryan F.,Rotello Vincent M.
Abstract
Bacterial infections cause 300 million cases of severe illness each year worldwide. Rapidly accelerating drug resistance further exacerbates this threat to human health. While dispersed (planktonic) bacteria represent a therapeutic challenge, bacterial biofilms present major hurdles for both diagnosis and treatment. Nanoparticles have emerged recently as tools for fighting drug-resistant planktonic bacteria and biofilms. In this review, we present the use of nanoparticles as active antimicrobial agents and drug delivery vehicles for antibacterial therapeutics. We further focus on how surface functionality of nanomaterials can be used to target both planktonic bacteria and biofilms.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference71 articles.
1. Estimating the burden of disease from water, sanitation, and hygiene at a global level.;A Prüss;Environ Health Perspect.,2002
2. Bacterial biofilms in nature and disease.;J Costerton;Annu Rev Microbiol.,1987
3. Bacterial biofilms: a common cause of persistent infections.;J Costerton;Science.,1999
4. Trends in antimicrobial drug development: implications for the future.;B Spellberg;Clin Infect Dis.,2004
5. Applications of Nanoparticles in Biology.;M De;Adv Mater.,2008
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献